PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI-Resistant Metastatic Clear Cell Renal Cell Carcinoma.

Cancer research and treatment（2023）

引用 2|浏览5

暂无评分

摘要

These results showed that PD-L1 expression may be increased in a subset of VEGFR-TKI-resistant mCCRCC patients via the mTOR pathway.

查看译文

关键词

B7-H1 antigen,Receptor protein-tyrosine kinases,Renal cell carcinoma,TOR serine-threonine kinases

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要